Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-06-10 16:05:57
Reporting Period:
Accepted Time:
2019-06-10 16:05:57
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1104506 Insmed Inc INSM Pharmaceutical Preparations (2834) 541972729
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1401017 Nicole S Orlov Schaeffer 10 Finderne Avenue
Building 10
Bridgewater NJ 08807
Chief People Strategy Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Stock Option Acquisiton 2019-06-06 12,000 $6.96 36,350 No 4 M Direct
Stock Option Disposition 2019-06-06 12,000 $23.24 24,350 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-06-06 12,000 $0.00 12,000 $6.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,226 2023-01-02 No 4 M Direct
  1. This is the weighted average sales price representing 12,000 shares sold at prices ranging from $23.00 to $23.66 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
  2. Stock options granted under the Company's 2000 Incentive Plan. These stock options are currently exercisable.